Rockwell Medical (RMTI) Operating Expenses (2010 - 2026)

Rockwell Medical (RMTI) has reported Operating Expenses for 17 consecutive years, with $4.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 10.7% year-over-year to $4.3 million; the trailing twelve-month figure through Jun 2026 stood at $16.8 million (changed 0.4% YoY), and the FY2025 full-year result was $16.4 million, down 2.79% from the prior year.
• Operating Expenses declined to $4.3 million in Q2 2026 per RMTI's latest filing, from $4.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $5.7 million in Q2 2022 and bottomed at $3.2 million in Q4 2023.
• Historically, Operating Expenses has averaged $4.2 million across 5 years, with a median of $4.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 32.91% in 2023, then advanced 27.7% in 2024.
• Over 5 years, Operating Expenses stood at $4.0 million in 2022, then retreated by 17.85% to $3.2 million in 2023, then rose by 27.7% to $4.1 million in 2024, then rose by 3.06% to $4.3 million in 2025, then dropped by 0.28% to $4.3 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $4.3 million, $4.4 million, and $4.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.